ProFunds Biotechnology UltraSector Fund Investor Class (BIPIX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
41.82
-0.55 (-1.30%)
Jul 24, 2025, 4:00 PM EDT
-1.30% (1Y)
| Fund Assets | 61.68M |
| Expense Ratio | 1.56% |
| Min. Investment | $15,000 |
| Turnover | 196.00% |
| Dividend (ttm) | 13.15 |
| Dividend Yield | 31.87% |
| Dividend Growth | 218.55% |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Dec 31, 2024 |
| Previous Close | 42.37 |
| YTD Return | -7.16% |
| 1-Year Return | -39.56% |
| 5-Year Return | -31.98% |
| 52-Week Low | 30.47 |
| 52-Week High | 73.53 |
| Beta (5Y) | 1.35 |
| Holdings | 134 |
| Inception Date | Jun 19, 2000 |
About BIPIX
The investment seeks daily investment results, before fees and expenses, that correspond to one and one-half times (1.5x) the daily performance of the Dow Jones U.S. BiotechnologySM Index. The fund invests in financial instruments that the adviser believes, in combination, should produce daily returns consistent with its investment objective. The index seeks to measure the performance of certain companies in the biotechnology sector of the U.S. equity market. The fund is non-diversified.
Fund Family ProFunds
Category Trading--Leveraged Equity
Stock Exchange NASDAQ
Ticker Symbol BIPIX
Share Class Investor Class
Index Dow Jones US Biotechnology TR
Performance
BIPIX had a total return of -39.56% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.08%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| BIPSX | Service Class | 2.56% |
Top 10 Holdings
30.65% of assets| Name | Symbol | Weight |
|---|---|---|
| SOCIETE' GENERALE 4.23 , 5/01/2025 | n/a | 6.63% |
| HSBC SECURITIES (USA), INC. 4.28 , 5/01/2025 | n/a | 6.29% |
| Short-Term Investment Trust - Invesco Government & Agency Portfolio | AGPXX | 3.25% |
| CREDIT AGRICOLE CIB NY 4.24 , 5/01/2025 | n/a | 2.38% |
| NATWEST MARKETS PLC 4.23 , 5/01/2025 | n/a | 2.29% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.07% |
| Natera, Inc. | NTRA | 1.99% |
| Vertex Pharmaceuticals Incorporated | VRTX | 1.96% |
| UMB FINANCIAL CORP. B 4.1 , 5/01/2025 | n/a | 1.89% |
| Neurocrine Biosciences, Inc. | NBIX | 1.89% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 31, 2024 | $0.10468 | Jan 2, 2025 |
| Dec 27, 2024 | $13.04498 | Dec 30, 2024 |
| Dec 20, 2023 | $4.12801 | Dec 21, 2023 |
| Dec 21, 2020 | $8.0736 | Dec 21, 2020 |
| Dec 23, 2019 | $2.02988 | Dec 23, 2019 |
| Dec 27, 2018 | $2.86745 | Dec 27, 2018 |